Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)

Saeedeh Ghorbanalipoor; Shirin Emtenani; Melissa Parker; Mayumi Kamaguchi; Colin Osterloh; Manuela Pigors; Natalie Gross; Stanislav Khil’chenko; Anika Kasprick; Sabrina Patzelt; Diana Wortmann; Ibrahim O. Ibrahim; Kentaro Izumi; Stephanie Goletz; Katharina Boch; Kathrin Kalies; Katja Bieber; Paul Smith; Enno Schmidt; Ralf J. Ludwig

doi:10.3389/fimmu.2022.1099535

Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)

Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, Mayumi Kamaguchi, Colin Osterloh, Manuela Pigors, Natalie Gross, Stanislav Khil’chenko, Anika Kasprick, Sabrina Patzelt, Diana Wortmann, Ibrahim O. Ibrahim, Kentaro Izumi, Stephanie Goletz, Katharina Boch, Kathrin Kalies, Katja Bieber, Paul Smith, Enno Schmidt, Ralf J. Ludwig^*

^*Korrespondierende/r Autor/-in für diese Arbeit

2 Zitate (Scopus)

Abstract

In the published article, there was an error in the author list. The equal contribution of Saeedeh Ghorbanalipoor, Shirin Emtenani as first authors and that of Enno Schmidt and Ralf J. Ludwig as last authors had not been indicated. The corrected author list appears below.

Originalsprache	Englisch
Aufsatznummer	1099535
Zeitschrift	Frontiers in Immunology
Jahrgang	13
ISSN	1664-3224
DOIs	https://doi.org/10.3389/fimmu.2022.1099535
Publikationsstatus	Veröffentlicht - 30.11.2022

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)
Zentren: Center for Research on Inflammation of the Skin (CRIS)

DFG-Fachsystematik

2.21-05 Immunologie
2.22-19 Dermatologie

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Dokumente

10.3389/fimmu.2022.1099535

Weitere Links

Link to publication in Scopus

Fingerprint

Untersuchen Sie die Forschungsthemen von „Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)“. Zusammen bilden sie einen einzigartigen Fingerprint.

SFB 1526, PANTAU: Pathomechanismen Antikörpervermittelter Autoimmunerkrankungen
Sadik, C. (Sprecher*in, Koordinator*in), Zillikens, D. (Sprecher*in, Koordinator*in), Scheffold, A. (Projektleiter*in (PI)), Schmidt, E. (Projektleiter*in (PI)), Heine, G. (Projektleiter*in (PI)), Manz, R. (Projektleiter*in (PI)), Köhl, J. (Projektleiter*in (PI)), Ludwig, R. (Projektleiter*in (PI)), Peipp, M. (Projektleiter*in (PI)), Hammers, M. C. (Projektleiter*in (PI)), Verschoor, A. (Projektleiter*in (PI)), Karsten, C. (Projektleiter*in (PI)), Nimmerjahn, F. (Projektleiter*in (PI)), Hutloff, A. (Projektleiter*in (PI)), Ibrahim, S. (Projektleiter*in (PI)), Wettschureck, N. (Projektleiter*in (PI)), Bieber, K. (Projektleiter*in (PI)), Schilf, P. (Projektleiter*in (PI)), Vaeth, M. (Projektleiter*in (PI)), Hirose, M. (Projektleiter*in (PI)), Vaeth, M. (Projektleiter*in (PI)), Baines, J. F. (Projektleiter*in (PI)), Bacher, P. (Projektleiter*in (PI)), Hoffmann, M. (Projektleiter*in (PI)), Busch, H. S. (Projektleiter*in (PI)), Höppner, M. (Projektleiter*in (PI)), Becker, M. (Projektleiter*in (PI)), Holtsche, M. M. (Projektleiter*in (PI)), Fähnrich, A. (Projektleiter*in (PI)), Szymczak, S. (Projektleiter*in (PI)), Murthy, S. (Projektleiter*in (PI)) & Lux, A. (Projektleiter*in (PI))
01.01.22 → …
Projekt: DFG-Projekte › DFG-Verbundforschung: Sonderforschungsbereiche/ Transregios

Zitieren

Ghorbanalipoor, S., Emtenani, S., Parker, M., Kamaguchi, M., Osterloh, C., Pigors, M., Gross, N., Khil’chenko, S., Kasprick, A., Patzelt, S., Wortmann, D., Ibrahim, I. O., Izumi, K., Goletz, S., Boch, K., Kalies, K., Bieber, K., Smith, P., Schmidt, E., & Ludwig, R. J. (2022). Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241). Frontiers in Immunology, 13, Artikel 1099535. https://doi.org/10.3389/fimmu.2022.1099535

@article{e03df55312534121906cc42fdf3f09a9,

title = "Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)",

abstract = "In the published article, there was an error in the author list. The equal contribution of Saeedeh Ghorbanalipoor, Shirin Emtenani as first authors and that of Enno Schmidt and Ralf J. Ludwig as last authors had not been indicated. The corrected author list appears below.",

author = "Saeedeh Ghorbanalipoor and Shirin Emtenani and Melissa Parker and Mayumi Kamaguchi and Colin Osterloh and Manuela Pigors and Natalie Gross and Stanislav Khil{\textquoteright}chenko and Anika Kasprick and Sabrina Patzelt and Diana Wortmann and Ibrahim, {Ibrahim O.} and Kentaro Izumi and Stephanie Goletz and Katharina Boch and Kathrin Kalies and Katja Bieber and Paul Smith and Enno Schmidt and Ludwig, {Ralf J.}",

note = "Publisher Copyright: {\textcopyright} 2022 Ghorbanalipoor, Emtenani, Parker, Kamaguchi, Osterloh, Pigors, Gross, Khil{\textquoteright}chenko, Kasprick, Patzelt, Wortmann, Ibrahim, Izumi, Goletz, Boch, Kalies, Bieber, Smith, Schmidt and Ludwig.",

year = "2022",

month = nov,

day = "30",

doi = "10.3389/fimmu.2022.1099535",

language = "English",

volume = "13",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media",

}

Ghorbanalipoor, S , Emtenani, S, Parker, M, Kamaguchi, M, Osterloh, C , Pigors, M , Gross, N, Khil’chenko, S, Kasprick, A, Patzelt, S, Wortmann, D, Ibrahim, IO, Izumi, K, Goletz, S, Boch, K, Kalies, K , Bieber, K, Smith, P, Schmidt, E & Ludwig, RJ 2022, 'Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)', Frontiers in Immunology, Jg. 13, 1099535. https://doi.org/10.3389/fimmu.2022.1099535

Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241). / Ghorbanalipoor, Saeedeh ; Emtenani, Shirin; Parker, Melissa et al.
in: Frontiers in Immunology, Jahrgang 13, 1099535, 30.11.2022.

Publikation: Beiträge in Fachzeitschriften › Kommentare/Debatten

TY - JOUR

T1 - Corrigendum to

T2 - Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)

AU - Ghorbanalipoor, Saeedeh

AU - Emtenani, Shirin

AU - Parker, Melissa

AU - Kamaguchi, Mayumi

AU - Osterloh, Colin

AU - Pigors, Manuela

AU - Gross, Natalie

AU - Khil’chenko, Stanislav

AU - Kasprick, Anika

AU - Patzelt, Sabrina

AU - Wortmann, Diana

AU - Ibrahim, Ibrahim O.

AU - Izumi, Kentaro

AU - Goletz, Stephanie

AU - Boch, Katharina

AU - Kalies, Kathrin

AU - Bieber, Katja

AU - Smith, Paul

AU - Schmidt, Enno

AU - Ludwig, Ralf J.

N1 - Publisher Copyright: © 2022 Ghorbanalipoor, Emtenani, Parker, Kamaguchi, Osterloh, Pigors, Gross, Khil’chenko, Kasprick, Patzelt, Wortmann, Ibrahim, Izumi, Goletz, Boch, Kalies, Bieber, Smith, Schmidt and Ludwig.

PY - 2022/11/30

Y1 - 2022/11/30

N2 - In the published article, there was an error in the author list. The equal contribution of Saeedeh Ghorbanalipoor, Shirin Emtenani as first authors and that of Enno Schmidt and Ralf J. Ludwig as last authors had not been indicated. The corrected author list appears below.

AB - In the published article, there was an error in the author list. The equal contribution of Saeedeh Ghorbanalipoor, Shirin Emtenani as first authors and that of Enno Schmidt and Ralf J. Ludwig as last authors had not been indicated. The corrected author list appears below.

UR - http://www.scopus.com/inward/record.url?scp=85144017387&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2022.1099535

DO - 10.3389/fimmu.2022.1099535

M3 - Comments/Debates

C2 - 36532003

AN - SCOPUS:85144017387

SN - 1664-3224

VL - 13

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1099535

ER -

Ghorbanalipoor S , Emtenani S, Parker M, Kamaguchi M, Osterloh C , Pigors M et al. Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241). Frontiers in Immunology. 2022 Nov 30;13:1099535. doi: 10.3389/fimmu.2022.1099535

Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)

Abstract

Strategische Forschungsbereiche und Zentren

DFG-Fachsystematik

UN SDGs

Dokumente

Weitere Links

Fingerprint

Projekte

SFB 1526, PANTAU: Pathomechanismen Antikörpervermittelter Autoimmunerkrankungen

Zitieren